Latest News and Press Releases

Want to stay updated on the latest news?

Sign into Reader Account Create Reader Account

April 10, 2024 07:00 ET | Source: Spectral Medical Inc.

Spectral Medical Provides Tigris Trial Update

101 patients enrolled TORONTO, April 10, 2024 (GLOBE NEWSWIRE) -- Spectral Medical Inc. (“Spectral” or the “Company”) (TSX: EDT), a late-stage theranostic company advancing therapeutic options for...
April 02, 2024 08:00 ET | Source: Spectral Medical Inc.

Spectral Medical Chair to Retire From the Board of Directors

TORONTO, April 02, 2024 (GLOBE NEWSWIRE) -- Spectral Medical Inc. (“Spectral” or the “Company”) (TSX: EDT), a late-stage theranostic company advancing therapeutic options for sepsis and septic...
March 28, 2024 16:00 ET | Source: Spectral Medical Inc.

Spectral Medical Announces Fourth Quarter and Fiscal 2023 Results and Provides Corporate Update

TORONTO, March 28, 2024 (GLOBE NEWSWIRE) -- Spectral Medical Inc. (“Spectral” or the “Company”) (TSX: EDT), a late-stage theranostic company advancing therapeutic options for sepsis and septic...
February 28, 2024 07:30 ET | Source: Spectral Medical Inc.

Spectral Medical Provides February Tigris Trial Update

93 patients enrolledFebruary represents a second record breaking consecutive month for patient enrollment TORONTO, Feb. 28, 2024 (GLOBE NEWSWIRE) -- Spectral Medical Inc. (“Spectral” or the...
February 21, 2024 16:00 ET | Source: Spectral Medical Inc.

Spectral Medical Announces Amendment and Extension of Exclusive Supply and Distribution Agreement With Baxter Healthcare Corporation

TORONTO, Feb. 21, 2024 (GLOBE NEWSWIRE) -- Spectral Medical Inc. (“Spectral” or the “Company”) (TSX: EDT), a late-stage theranostic company advancing therapeutic options for sepsis and septic shock,...
February 15, 2024 07:41 ET | Source: Spectral Medical Inc.

Spectral Medical Announces Major Milestone by Reaching Its Interim Enrollment Target of 90 Patients

TORONTO, Feb. 15, 2024 (GLOBE NEWSWIRE) -- Spectral Medical Inc. (“Spectral” or the “Company”) (TSX: EDT), a late-stage theranostic company advancing therapeutic options for sepsis and septic shock,...
February 05, 2024 07:30 ET | Source: Spectral Medical Inc.

Spectral Medical Provides Early February Tigris Trial Update

88 patients enrolled January being the highest enrollment month since the launch of Tigris TORONTO, Feb. 05, 2024 (GLOBE NEWSWIRE) -- Spectral Medical Inc. (“Spectral” or the...
January 30, 2024 07:30 ET | Source: Spectral Medical Inc.

Spectral Medical Provides January Tigris Trial Update

TORONTO, Jan. 30, 2024 (GLOBE NEWSWIRE) -- Spectral Medical Inc. (“Spectral” or the “Company”) (TSX: EDT), a late-stage theranostic company advancing therapeutic options for sepsis and septic shock,...
January 10, 2024 07:00 ET | Source: Spectral Medical Inc.

Spectral Medical Enrolls Patient 82 in Its Phase 3 FDA Tigris Septic Shock Trial

New patient enrollment sites accelerating screening activityScreening activity exceeding 100 patients per weekApproaching interim enrollment target of 90 patients TORONTO, Jan. 10, 2024 (GLOBE...
December 14, 2023 08:00 ET | Source: Spectral Medical Inc.

Spectral Medical Provides Tigris Trial Update

81 patients enrolled TORONTO, Dec. 14, 2023 (GLOBE NEWSWIRE) -- Spectral Medical Inc. (“Spectral” or the “Company”) (TSX: EDT), a late-stage theranostic company advancing therapeutic options for...